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Abstract
In the last decade, proteogenomics has emerged as a valuable technique that contributes to the 
state-of-the-art in genome annotation. However, previous proteogenomic studies were limited to 
bottom-up mass spectrometry and did not take advantage of top-down approaches. We show that 
top-down proteogenomics allows one to address the problems that remained beyond the reach of 
traditional bottom-up proteogenomics. In particular, we show that top-down proteogenomics leads 
to discovery of previously unannotated genes even in extensively studied bacterial genomes and 
present SpectroGene – a software tool for genome annotation using tandem top-down spectra. We 
further show that top-down proteogenomics searches (against the 6-frame translation of a genome) 
identify nearly all proteoforms found in traditional top-down proteomics searches (against the 
annotated proteome). SpectroGene is freely available at http://github.com/fenderglass/SpectroGene
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Introduction
Bottom-up proteogenomics is now a mature area that proved to be valuable for improving 
genome annotations in both prokaryotes1–5 and eukaryotes6–8. E.g., Kucharova and Wiker9 
discussed over a hundred papers aimed at annotating various genomes in a recent review 
focusing on bacterial proteogenomics. However, previous proteogenomics studies focused 
on bottom-up mass spectrometry and have not utilized the power of top-down proteomics 
yet.
While bottom-up bacterial proteogenomics has been successful, prediction of short genes, 
annotation of genes with unusual codon usage, and accurate prediction of Start codons 
remains a challenge. Moreover, the capabilities of bottom-up proteogenomics for solving 
such challenging problems as annotating post-translational modifications (chemical 
modifications, signal peptides, proteolytic events) are limited because it provides only partial 
coverage of various proteoforms by short peptides.
In addition to proteogenomics, ribosome profiling (Ribo-seq) is another recently introduced 
approach to genome annotation that enabled the direct observation of protein synthesis at the 
transcript level. While Ribo-seq resulted in recent discoveries of elusive (often short) 
proteins forming a “hidden proteome”, it may generate false predictions10. Thus, it needs to 
be complemented by more reliable techniques for validating gene annotations11. Bottom-up 
proteogenomics is not an ideal way to validate Ribo-seq data since elusive short proteins in 
“hidden proteome” often lack identified peptides or are represented by less reliable “one-hit-
wonders”.12 Top-down proteogenomics, on the other hand, provides a full-length protein 
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coverage and can potentially identify the entire short protein if it is expressed at the 
detectable level.
We emphasize that bottom-up and top-down proteogenomics have unique strengths and 
limitations and thus represent complementary approaches. E.g., while top-down 
proteogenomics generates a full-length protein coverage, its applications are mainly limited 
to identification of relatively short proteins. Thus, ideally bottom-up and top-down 
approaches should be combined together13.
Below we describe SpectroGene software tool for top-down proteogenomics and benchmark 
it on a large set of top-down mass spectra from Salmonella Typhimurium.
Methods
Top-down protein identification
In this study, we used TopPIC14 for all protein identifications. TopPIC is a modification of 
MS-Align+15 with improved ability to characterize post-translational modifications. 
Similarly to other top-down database search tools, TopPIC has ability to identify 
proteoforms with large N- and C-terminal modifications as well as multiple modifications on 
internal residues. An important feature of TopPIC is the ability to generate accurate P-values 
and E-values of Protein-Spectrum Matches (PrSMs), a prerequisite for a reliable prediction 
of new genes.
TopPIC extends MS-Align+ by improved PTM localization in the found PrSMs, computing 
the confidence scores of the candidate PTM sites, and utilizing triplets of CID/HCD/ETD 
spectra for PrSM search. It also optimizes MS-Align+ in a variety of ways: (i) indexing 
protein databases to reduce the memory footprint in the MS/MS database search; (ii) 
improved filtering algorithm to increase the sensitivity of spectral identification; (iii) an 
improved spectral alignment algorithm allowing users to specify the range of unexpected 
mass shifts; (iv) a lookup table-based approach to speed up the computation of P-values and 
E-values of PrSMs16.
Forming ORFeome
The existing top-down tools ProsightPC17, MS-Align+15 and TopPIC14 were designed for 
finding PrSMs by searching all spectra against all annotated proteins in a proteome. When 
the proteome is unknown, we build an OR-Feome by breaking the six-frame translation of 
the genome into Open Reading Frames (ORFs). The Stop codons break the sequence of n/3 
codons in each of frame of the n-nucleotide long genome into segments between every pair 
of consecutive Stop codons. The suffixes of these segments that begin at the first Start codon 
within a segment form ORFs. ORFs within a single genomic sequence may overlap because 
there are six possible reading frames.
Most spectra identified in this study can be found by a simple TopPIC search against all 
ORFs. However, we found that this simple search fails to identify some spectra resulting 
from short proteoforms within long ORFs. Such “lost” identifications are often caused by 
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the heuristic filtration step in TopPIC that trades accuracy for speed15,18. Thus, to increase 
the number of identified spectra, we used the ORF splitting approach described below.
We divide all ORFs from six-frame translation into short (length does not exceed a 
predefined length threshold L) and long (length exceeds L). We further split long ORFs into 
overlapping windows of length L, such that the consecutive windows overlap by L/2 
nucleotides (see Figure 1). Tiling long ORFs by the overlapping windows is important since 
otherwise there is a risk of missing PrSMs that span two consecutive windows.
While ORF splitting addresses one of the limitations of TopPIC (identifications of a 
spectrum arising from a short proteoform within a long protein), TopPIC may also miss a 
proteoform spanning over multiple windows if the window length L is too short. To address 
this limitation of TopPIC, we generate the ORFeome for a range of window lengths. The 
default values of L are 50,200,500 (L = 500 represents the limit for the length proteins 
typically identified by top-down mass spectrometry). We note that other reasonable values of 
parameter L result in similar sets of identified spectra.
Identifying Protein-Spectrum Matches
Each spectrum may have multiple matches against the ORFeome for various window lengths 
L. We select a single match corresponding to a PrSM with the minimum P-value for a given 
spectrum. PrSMs with the E-values below a threshold are reported (0.01 is the default E-
value threshold for SpectroGene). We refer to proteins/peptides that correspond to these 
PrSMs as proteoforms19. The E-value of a proteoform is defined as the minimum E-value of 
all PrSMs that correspond to this proteoform. See Figure 2a for a diagram illustrating the 
concept of a proteoform.
Annotating genomes by proteoforms
SpectroGene combines identified proteoforms into ORF clusters in such a way that 
proteoforms from the same cluster belong to the same ORF in the six-frame translation of 
the genome. Note, that while proteoforms from the same ORF cluster belong to the same 
ORF, they do not necessarily cover the full length of the ORF. We define the first/last amino 
acid of the ORF cluster as the first/last amino acid across all its proteoforms. The length of 
the ORF cluster is defined as the number of amino acids between its first and last amino 
acids The ORF cluster is typically shorter than the corresponding ORF. See Figure 2b for a 
diagram illustrating the concept of the ORF cluster.
Software
SpectroGene is an easy-to-use open source software written in Python and freely available at 
http://github.com/fenderglass/SpectroGene. It takes as input (i) deconvoluted top-down 
spectra and (ii) genomic sequence and outputs the report describing the found proteoforms 
and ORF clusters. TopPIC is included into the distribution. Additionally, a user can provide 
a set of annotated proteins to perform conventional database search against a proteome.
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Results
Datasets
We benchmarked SpectroGene on a large top-down spectral dataset from Salmonella 
Typhimurium strain LT2 containing 22,683 spectra13 and a small top-down spectral dataset 
from Pyrococcus furiosus containing 1,198 spectra20. Below we provide the detailed 
description of the benchmarking results for the large dataset and a brief description for the 
small dataset.
This large dataset was generated using single-dimension ultra–high-pressure liquid 
chromatography (UPLC) system coupled with a Velos-Orbitrap mass spectrometer to profile 
the intact S. Typhimurium proteome. S. Typhimurium genome (4,86 millions nucleotides in 
length) has 4,451 annotated proteins. 427 of them are relatively short proteins (shorter than 
100 amino acids in length) that are often difficult to predict using existing software tools for 
bacterial gene prediction21,22. Proteome was downloaded from the UniProt database 
(accession number UP000001014, only chromosomal genes were considered).
The small dataset was generated using capillary electrophoresis (CE) through a sheathless 
capillary electrophoresis-electrospray ionization (CESI) interface coupled to an Orbitrap 
Elite mass spectrometer20. The Pyrococcus Furiosus proteome was down-loaded from the 
UniProt database (accession number UP000001013).
Comparison of SpectroGene with conventional protein database search
We first benchmarked SpectroGene against the conventional proteome database search. To 
make this comparison, we performed a SpectroGene run referred as a genome run 
(comparing all spectra against the genome) and a proteome run which is described as 
follows.
We first perform a conventional search against a known proteome using TopPIC with the 
same parameters as in the genome run. Then we project the found proteoforms on the 
genome by aligning their amino acid sequences on the genomic sequence using BLAST. 
ORF clusters of the proteome run are defined in the same way as in the genome run.
SpectroGene identified 2,665 proteoforms from 599 distinct ORF clusters in the genome 
run, while TopPIC identified 2,600 proteoforms from 598 distinct ORF clusters in the 
proteome run. Figure 3 shows the distribution of lengths of identified proteoforms, ORF 
clusters, and ORFs in the genome run. ORF clusters that were identified by SpectroGene 
cover 584 out of 598 (97%) ORF clusters identified in the proteome run. The fact that nearly 
all ORF clusters identified in the proteome run were also identified in the genome run 
underscores the potential of top-down proteomics for genome annotation.
A slightly larger number of proteoforms/ORF clusters identified in the genome run does not 
imply that the genome runs are superior to the proteome runs but is rather an indication that 
there are fewer constraints in identifying the endpoints of putative proteoform when the 
proteome is unknown Liu et al.15. In some cases, these endpoints are not true ends of 
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proteoforms but rather computational artifacts since all top-down tools are prone to errors in 
the case of large modifications and errors in estimating the precursor masses.
Next, we assess how accurate SpectroGene is with respect to identification of specific gene 
features, e.g., translational start sites (referred to as gene starts) or signal peptides. We refer 
to an ORF cluster as the gene end if it ends right before the Stop codon. We refer to an ORF 
cluster as a potential gene start if either (i) its first codon is a Start codon (ATG, GTG, or 
TTG) or (ii) its preceding codon is a Start codon and its first amino acid is Gly, Ala, Ser, 
Cys, Thr, Pro, or Val. The condition (ii) accounts for N-terminal Methionine Cleavage 
(NME) that removes the initial methionine from proteins whose second residue is Gly, Ala, 
Ser, Cys, Thr, Pro, or Val23. We say that an ORF cluster reveals a potential signal peptide if 
its start precedes by the canonical signal peptide recognition motif A.A. Since the 
recognition sites for many signal peptides often deviate from the canonical A.A motif, we 
also specify a weaker test for the signal peptide motif that is limited to a single amino acid A 
at position −1. This rule results in a higher false positive but smaller false negative rates for 
the signal peptide detection. For each weak and strong signal peptide motif we measured the 
distance from a cut to the annotated gene start. The median value was equal to 22, which lies 
in the expected range for the length of signal peptides.
The statistics of ORF clusters corresponding to gene starts/ends (as well as potential signal 
peptides) for both genome and proteome runs are given in Table 1. As expected, many 
proteins are only partially covered by corresponding proteoforms. As the result, many ORF 
clusters do not begin with a Start codon or end with a Stop codon. However, there is a good 
agreement between the genome and the proteome searches with respect to the number of 
identified gene starts and ends.
Using SpectroGene to find new genes
Next, we analyze the differences between genome and proteome runs as the specific ORF 
clusters (identified in the genome run but not in the proteome run) may potentially represent 
genes that are currently not annotated.
Interestingly, most of the specific ORF clusters (that were identified in the genome run but 
not in the proteome run and vice versa) have significantly higher E-values than the average 
E-values of identified proteoforms (Figure 4). It is expected that, due to the larger search 
space, most proteoforms identified in the genome run have higher E-values than proteoforms 
identified in the proteome run. However, in some cases, proteoforms might have higher E-
value in the proteome comparing to the genome run (see the section below for comparing the 
E-values of proteoforms identified in proteome and genome searches).
14 ORF clusters identified in the proteome run were not identified in the genome run 
(proteoforms mapping to these ORF clusters have E-values varying from 10−2 to 10−10). 
Eight of them were identified by SpectroGene but were not reported because they had E-
values slightly above the threshold. Other six clusters either represent paralogous copies of 
the genes identified in the genome run or erroneous hits.
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15 ORF clusters were identified in the genome run but not in the proteome run. Six of them 
were found in the proteome run but were not reported since they had E-values slightly 
exceeding the threshold. For the remaining nine ORF clusters, we performed BLAST 
searches against the NCBI protein database. A BLAST hit of an ORF cluster against an 
annotated protein in another species represents a comparative genomics support for the 
hypothesis that the ORF cluster belongs to a yet unannotated gene in S. Typhimurium.
Seven out of nine ORF clusters had various statistically significant BLAST matches to 
annotated proteins in other bacteria thus suggesting that SpectroGene may complement the 
existing gene prediction tools. Figure 5 presents examples of two PrSMs from such ORF 
clusters with the lowest E-values (10−17 and 10−30) revealing potentially new genes in S. 
Typhimurium. For the remaining two out of nine of ORF clusters (without statistically 
significant BLAST hits), the proteoforms mapping to these ORF clusters had relatively high 
E-values (≈ 10−3). Thus, since we only have a borderline statistical evidence that these ORF 
clusters reveal new genes, we view them as potential false positives.
The proteoform shown in Figure 5(a) represents a short protein with unusually high fraction 
(45%) of proline residues. Such proline-rich proteins (PRPs) have been reported in various 
bacteria. While the function of most such proteins remains unclear, some of them have been 
implicated in signal transduction24. The proteolytic pathway that resulted in this 31 amino 
acids long proteoform remains unknown.
The proteoform shown in Figure 5(b) represents a short (59 amino acids) protein with −2 Da 
modification that suggests the disulfide bridge between two cysteins separated by seven 
amino acids. Since this proteoform starts at the first Methionine in an ORF and ends right 
before the Stop codon, it covers the entire gene.
Interestingly, the ORF clusters identified in the genome run contain 119 out of 427 (≈ 28%) 
proteins shorter than 100 amino acids in S. Typhimurium. This result indicates that top-down 
proteomics provides excellent coverage of the short proteome that is traditionally difficult to 
predict using existing gene prediction tools or validate using traditional bottom-up 
proteomics approaches. Indeed, the number of short proteins identified using our small top-
down dataset exceeds the number of short proteins identified using a large bottom-up 
bacterial dataset in Gupta et al.4 by an order of magnitude.
Using SpectroGene to improve gene annotations
Top-down proteogenomics has a potential to improve existing gene annotations by 
correcting missannotated gene starts. From the 169 ORF clusters identified in the genome 
run that were marked as gene starts, 139 show agreement with existing gene annotations. For 
the remaining 30 ORF clusters we observe a systematic shift of Start codons reported by 
SpectroGene to the right (with a median value of 16). Most of these shifts correspond to 
genes that are only partially covered by proteoforms. These proteoforms most likely 
correspond to proteolytically digested proteins, e.g., three of them start at the likely position 
of the signal peptide cleavage. However, we observe two interesting examples of alternative 
gene starts, which do not agree with proteome annotations and are also unlikely to be caused 
by proteolytic events (see Figure 6).
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Benchmarking SpectroGene using Pyrococcus furiosus dataset
SpectroGene identified 186 proteoforms from 91 distinct ORF clusters in the genome run 
and 178 proteoforms from 87 ORF clusters in the proteome run. 4 out of the 87 ORF 
clusters identified the proteome run did not overlap with proteins identified using 
ProsightPC in the original study20.
One ORF cluster from the proteome run was not identified in the genome run because its E-
value slightly exceeded the threshold. We also observe five ORF clusters (with E-values 
from 10−4 to 10−36) from the genome run that were missed in the proteome suggesting gaps 
in the proteome annotations. Four out of these five ORF clusters represent proteins that were 
not annotated in the proteome. Figure 7 illustrates the PrSM diagrams for two out of four 
ORF clusters specific to the genome run.
Interestingly, one of the five ORF clusters specific to the genome was not identified in the 
proteome run due to an apparent error in predicting the gene start for this ORF cluster (see 
Figure 8 for details). We observed 2 more discrepancies between the annotated and observed 
gene starts in P. furiosus.
SpectroGene performance
We benchmarked the running time and memory footprint of SpectroGene for both genome 
and proteome runs (see Table 2). The most time-consuming step of the algorithm is PrSM 
identification with TopPIC. However, this step could be done in parallel, which gives a 
significant speed-up.
To assess how E-values reported by SpectroGene correlate with false discovery rate (FDR) 
of SpectroGene searches, we used a variation of the target-decoy approach25 and randomly 
shuffled all sequences in both genome and proteome runs to generate the decoy database. 
We then calculated FDR as the ratio of the number of PrSMs found in the resulting decoy 
runs and the number of proteoforms in the found in the SpectroGene with the target 
database. The FDR was the proteome and the genome runs was estimated at 1.2% and 1.1%, 
respectively. Thus, the computed FDR correlates well with the E-value threshold 0.01 used 
for both runs.
Comparing E-values of PrSMs in genome and proteome searches
Since the size of the genome database is larger than the size of the proteome database, we 
expect that E-values of PrSMs in the genome run are larger than E-values of PrSMs in the 
proteome run. However, E-values in top-down searches are defined by both database size 
and p-values of PrSMs. Since computing exact p-values of PrSMs remains an open problem 
(Liu et al.15 only described an exact formula for the case of PrSMs formed by proteoforms 
without N- and C-terminal modifications), TopPIC approximates p-values using a heuristic 
approach. Since p-values of PrSMs in proteome searches may be larger than p-values of 
PrSMs in genome searches, E-values of some PrSMs in proteome searches are slightly larger 
than E-values of these PrSMs in genome searches.
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Discussion
In recent years, proteogenomics has become especially relevant in microbiology where over 
30,000 bacterial genomes have been sequenced and where the limitations of existing gene 
prediction tools are well recognized. For example, a comparison of various state-of-the-art 
gene prediction tools for the sequences of Mycobacterium tuberculosis H37Rv and 
Halorhabdus utahensis showed up to 50% difference in the Start codon assignments26,27. In 
some bacterial genomes, these tools incorrectly assign nearly 60% of Start codons28.
The idea of searching tandem mass spectra against the translated genome (rather than 
derived proteome) in order to validate the existing annotation was introduced by Jaffe et al.
29
 and resulted in many bottom-up proteogenomics studies in the last decade. However, as 
Kucharova and Wiker9 noted in a recent review, bottom-up proteogenomics studies suffer 
from the rather low protein sequence coverage by peptides.
Top-down mass spectrometry has advantages in localizing multiple PTMs in a coordinated 
fashion and identifying multiple protein species (e.g. proteolytically processed protein 
species). In the last five years, because of advances in protein separation and top-down 
instrumentation, top-down mass spectrometry moved from analyzing single proteins to 
analyzing complex samples containing hundreds and even thousands of proteins thus 
opening new opportunities for proteogenomics annotations. However, computational tools 
for top-down proteogenomics are still missing.
In some applications, top-down proteogenomics clearly has advantages over bottom-up 
proteogenomics. For example, Bonissone et al.23 recently conducted a large bottom-up 
proteogenomics study of N-terminal protein processing by analyzing 112 million spectra 
from 57 bacterial organisms. However, bottom-up analysis of N-terminal processing of a 
given protein only succeeds if the N-terminal peptide in this protein is identified, the 
condition that holds only for a fraction of proteins identified in Bonissone et al.23. While 
various techniques for enrichment of N-terminal peptides have been used to improve start 
site annotations30,31, they are still rarely used in proteogenomics studies since they remain 
error prone and require additional experimental protocols. Top-down proteogenomics, on the 
other hand, identifies intact proteins and thus provides information on N-terminus of every 
identified proteoform.
All previous proteogenomics studies were based on bottom up mass spectrometry with the 
only exception is Ansong et al.13 that however has not resulted in a publicly available 
software tool for top-down proteogenomics. This study introduced SpectroGene, the first 
such tool that has a potential to be used in conjunction with each proteogenomics study of 
bacterial genomes. We have shown that, using unannotated genome, SpectroGene generates 
results that are in a good agreement with the state-of-the-art protein identification tools that 
use annotated genome, i.e., the protein database. We also identified some putative proteins 
that were missed by the search against the proteome database.
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Figure 1. 
Generating the ORFeome. Start and Stop codons are shown in green and red, respectively. 
ORFs longer than L are partitioned into overlapping windows of length L to increase the 
sensitivity of PrSM identifications.
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Figure 2. 
A diagram illustrating the concepts of proteoforms and ORF clusters. Start and Stop codons 
are shown in green and red respectively.
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Figure 3. 
The distribution of lengths of proteoforms (a), ORF clusters (b), and ORFs (c) identified in 
the genome run. The increased proportion of longer ORF clusters comparing to the median 
proteoform length is explained by the fact that some long proteins give rise to multiple short 
proteoforms. One ORF cluster and six ORFs with lengths exceeding 1000 aa are not shown.
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Figure 4. 
Histogram of log-scaled E-values of ORF clusters found in genome/proteome run that have 
(blue) or do not have (red and green) a “matching” ORF cluster in proteome/genome run 
respectively. E-value of an ORF cluster is defined as the lowest E-value among all 
proteoforms that belong to this ORF cluster. While most of ORF clusters without match 
have higher E-values than the median E-value of all identified proteoforms, a few ORF 
clusters have relatively low E-values. These ORF clusters reveal previously unannotated 
genes or represent paralogous gene copies.
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Figure 5. 
MS-Align+ logos of PrSMs. Symbols in bold represent proteoforms with red brackets on its 
ends, while gray symbols show flanking genomic sequence between two consecutive stop 
codons. Symbols  and  refer to the b- and y- ions. Symbol  refere to the case when both b- 
and y-ions are present in the spectrum. Putative Start codons are shown in green. Stop 
codons are indicated by “*” signs. Blue background marks a possible location of the PTM 
with the mass shift −2.01 shown on top. Since TopPIC is unable to place this PTM on a 
specific residue, it assigns it to one of the six residues shown in the blue background.
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Figure 6. 
Examples of gene start corrections using identified proteoforms. Putative Start codons are 
marked in green. Since the observed gene starts are located after the annotated gene starts, 
the gene start corrections in these examples can be made based on both genome and 
proteome runs.
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Figure 7. 
MS-Align+ logos of PrSMs found in P. furosus genome that are not annotated in the 
proteome. All PrSMs have statistically significant BLAST hits against (identical) 
computationally predicted hypothetical proteins in P. furiosus.
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Figure 8. 
A proteoform representing the Iron-dependent repressor of P. furiosus reveals the likely error 
in the gene start annotation. As a consequence, this proteoform was not identified in the 
proteome run.
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Table 1
Statistics of ORF clusters identified in the proteome run and in the genome runs.
Statistics Proteome run Genome run
#PrSMs 8539 8368
#proteoforms 2600 2665
#ORF clusters 598 599
Median ORF cluster length 99 99
Gene start 175 (29%) 169 (28%)
Gene end 329 (55%) 326 (54%)
Gene start AND gene end 183 (30%) 172 (28%)
Neither gene start nor gene end 205 (34%) 210 (35%)
Precedes by the canonical signal peptide motif A.A 30 (5%) 31 (5%)
Precedes by the weak signal peptide motif A 79 (13%) 78 (13%)
J Proteome Res. Author manuscript; available in PMC 2018 June 27.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Kolmogorov et al. Page 21
Table 2
Speed and memory usage statistics of SpectroGene. Benchmarks were performed on S. Typhimurium and 
P.Furiosus datasets. SpectroGene was run in parallel on a cluster with 20 Intel Xenon cores.
S. Typhimurium P. Furiosus
Proteome Genome Proteome Genome
Database size (Mb) 1.5 10 0.8 3.7
Number of spectra 22, 638 22, 638 1, 221 1, 198
Running time (min) 2307 4784 74 164
Memory usage (Gb) 76 76 76 76
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